TELECOBALT THERAPY FOR CARCINOMA OF LARYNGOPHARYNX

1 January 1971

journal article
Published by American Roentgen Ray Society in American Journal of Roentgenology

Vol. 111 (1) , 78-84
https://doi.org/10.2214/ajr.111.1.78

Abstract

1. In small lesions, T1 and T2, of the laryngopharynx, telecobalt therapy gives as good results as the combination of surgery anti pre- and postoperative telecobalt therapy.2. On the other hand, in larger lesions, T3 and T4, surgery supplemented by radiotherapy seems to be the best treatment.3. Surgery after telecobalt therapy in carcinoma of the laryngopharynx is difficult. This must be kept in mind when designing a preoperative irradiation program. The dose in curable lesions should not exceed 3,000 r, with a weekly dose of 1,000 r.4. Radiosensitivity of laryngopharynx cancers varies greatly from one patient to another. However, the best chance of cure is afforded by doses between 6,500 and 7,500 r.

Keywords

This publication has 0 references indexed in Scilit: